Pfizer Ltd

Information

Name

Pfizer Ltd

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

https://etendersni.gov.uk/epps

Address

Tadworth

United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Pfizer Ltd
Sign up free

Contracts awarded to Pfizer Ltd

The contracts that Pfizer Ltd have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 6 months ago

NHS National Generic Pharmaceuticals Wave 14c

NHS National Generic Pharmaceuticals- Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)

£219
Award

Published 8 months ago

NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines

This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

£33,081,281
Award

Published 8 months ago

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 Offer reference number: CM/PHR/22/5678 CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months

£74
Award

Published 8 months ago

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 Offer reference number: CM/PHR/22/5678 CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

£580,156,000 Bids close: 11 months ago
Award

Published 8 months ago

Generic, Branded Generic & Proprietary Medicinal Products - Group 13

Generic, Branded Generic & Proprietary Medicinal Products - Group 13 (4844244)

£13,838,930

Contacts

+44 7471112086

[email protected]

Statistics (1 Year)

Contracts Won

Total Won

£1,497,962,041

Average Win

£299,592,408

Pfizer Ltd

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Pfizer Ltd

NHS National Generic Pharmaceuticals Wave 14c

NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

Generic, Branded Generic & Proprietary Medicinal Products - Group 13

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win